Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pulmonology
Volume 2015, Article ID 136970, 6 pages
http://dx.doi.org/10.1155/2015/136970
Case Report

Lung Cancer with Skin and Breast Metastasis: A Case Report and Literature Review

Department of Medicine, Interfaith Medical Center, 1545 Atlantic Avenue, Brooklyn, NY 11213, USA

Received 30 December 2014; Accepted 28 February 2015

Academic Editor: Akif Turna

Copyright © 2015 Bikash Bhattarai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Brambilla and W. D. Travis, “Lung cancer,” in World Cancer Report, B. W. Stewart and C. P. Wild, Eds., World Health Organization, Lyon, France, 2014. View at Google Scholar
  2. R. Siegel, J. Ma, Z. Zou, and A. Jemal, “Cancer statistics, 2014,” CA Cancer Journal for Clinicians, vol. 64, no. 1, pp. 9–29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. http://seer.cancer.gov/csr/1975_2004/results_merged/sect_15_lung_bronchus.pdf.
  4. T. Rosen, “Cutaneous metastases,” Medical Clinics of North America, vol. 65, no. 5, pp. 885–900, 1980. View at Google Scholar · View at Scopus
  5. F. Altintoprak, H. F. Baytekin, and C. Tasdemir, “Primary small cell carcinoma of the lung presenting with breast and skin metastases,” The Korean Journal of Internal Medicine, vol. 26, no. 2, pp. 207–209, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. M. H. Brownstein and E. B. Helwig, “Metastatic tumors of the skin,” Cancer, vol. 29, no. 5, pp. 1298–1307, 1972. View at Publisher · View at Google Scholar · View at Scopus
  7. D. H. Connor, H. B. Taylor, and E. B. Helwig, “Cutaneous metastasis of renal cell carcinoma,” Archives of Pathology, vol. 76, pp. 339–346, 1963. View at Google Scholar
  8. E. Ask­Upmark, “Clinical aspects of tumor metastases,” Nordisk Medicin, vol. 56, no. 40, pp. 1433–1440, 1956. View at Google Scholar · View at Scopus
  9. National Comprehensive Cancer Network, NCCN Clinical Practice Guidelines in Oncology, Non-Small Cell Lung Cancer V2, National Comprehensive Cancer Network, 2012, http://www.nccn.org/professionals/physician_gls/PDF/nscl.pdf.
  10. D. P. Lookingbill, N. Spangler, and F. M. Sexton, “Skin involvement as the presenting sign of internal carcinoma. A retrospective study of 7316 cancer patients,” Journal of the American Academy of Dermatology, vol. 22, no. 1, pp. 19–26, 1990. View at Publisher · View at Google Scholar · View at Scopus
  11. D. W. Perng, C. H. Chen, Y. C. Lee, and R. P. Perng, “Cutaneous metastasis of lung cancer: an ominous prognostic sign,” Chinese Medical Journal, vol. 57, no. 5, pp. 343–347, 1996. View at Google Scholar · View at Scopus
  12. L. M. Coslett and M. R. Katlic, “Lung cancer with skin metastasis,” Chest, vol. 97, no. 3, pp. 757–759, 1990. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Dreizen, H. M. Dhingra, D. F. Chiuten, T. Umsawasdi, and M. Valdivieso, “Cutaneous and subcutaneous metastases of lung cancer. Clinical characteristics,” Postgraduate Medicine, vol. 80, no. 8, pp. 111–116, 1986. View at Google Scholar · View at Scopus
  14. M. H. Brownstein and E. B. Helwig, “Patterns of cutaneous metastasis,” Archives of Dermatology, vol. 105, no. 6, pp. 862–868, 1972. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Neel and A. Sober, “Metastatic tumors to the skin,” in Cancer Medicine, D. Kufe, R. Bast, E. Frei et al., Eds., Section 32, Subsection 123, B. C. Decker Incorporated, Danbury, Conn, USA, 2003. View at Google Scholar
  16. R. Y. Rubinstein, S. Baredes, J. Caputo, L. Galati, and R. A. Schwartz, “Cutaneous metastatic lung cancer: literature review and report of a tumor on the nose from a large cell undifferentiated carcinoma,” Ear, Nose and Throat Journal, vol. 79, no. 2, pp. 96–101, 2000. View at Google Scholar · View at Scopus
  17. S. Weitzner, “Cutaneous metastasis confined to the scrotum. Report of two cases,” Rocky Mountain Medical Journal, vol. 67, no. 9, pp. 40–42, 1970. View at Google Scholar · View at Scopus
  18. I. Ahmed, “Cutaneous metastases,” in Dermatology, J. Bolognia, J. Jorrizo, T. Horn et al., Eds., pp. 1953–1956, Elsevier, 2003. View at Google Scholar
  19. Y. Kikuchi, A. Matsuyama, and K. Nomura, “Zosteriform metastatic skin cancer: report of three cases and review of the literature,” Dermatology, vol. 202, no. 4, pp. 336–338, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Kamble, L. Kumar, V. Kochupillai, A. Sharma, M. S. Sandoo, and B. K. Mohanti, “Cutaneous metastases of lung cancer,” Postgraduate Medical Journal, vol. 71, pp. 741–743, 1995. View at Google Scholar
  21. S. Saeed, C. A. Keehn, and M. B. Morgan, “Cutaneous metastasis: a clinical, pathological, and immunohistochemical appraisal,” Journal of Cutaneous Pathology, vol. 31, no. 6, pp. 419–430, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Hidaka, Y. Ishii, and S. Kitamura, “Clinical features of skin metastasis from lung cancer,” Internal Medicine, vol. 35, no. 6, pp. 459–462, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Azoulay, C. Adem, F. L. Pelletier, S. Barete, C. Francès, and F. Capron, “Skin metastases from unknown origin: role of immunohistochemistry in the evaluation of cutaneous metastases of carcinoma of unknown origin,” Journal of Cutaneous Pathology, vol. 32, no. 8, pp. 561–566, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. V. J. Marson, J. Mazieres, O. Groussard et al., “Expression of TTF-1 and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade,” Histopathology, vol. 45, no. 2, pp. 125–134, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Koca, Y. Ustundag, E. Kargi, G. Numanoglu, and H. C. Altinyazar, “A case with widespread cutaneous metastases of unknown primary origin: grave prognostic finding in cancer,” Dermatology Online Journal, vol. 11, no. 1, p. 16, 2005. View at Google Scholar · View at Scopus
  26. J. Rosai, “Special techniques in surgical pathology,” in Rosai and Ackerman's Surgical Pathology, vol. 1, pp. 37–91, Mosby, Philadelphia, Pa, USA, 9th edition, 2004. View at Google Scholar
  27. V. Ambrogi, G. Tonini, and T. C. Mineo, “Prolonged survival after extracranial metastasectomy from synchronous resectable lung cancer,” Annals of Surgical Oncology, vol. 8, no. 8, pp. 663–666, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. V. Ambrogi, I. Nofroni, G. Tonini, and T. C. Mineo, “Skin metastases in lung cancer: analysis of a 10-year experience,” Oncology Reports, vol. 8, no. 1, pp. 57–61, 2001. View at Google Scholar · View at Scopus
  29. M. J. Molina Garrido, C. G. Ponce, J. L. Soto Martínez, C. Martínez Y Sevila, A. C. Mena, and F. M. Antón, “Cutaneous metastases of lung cancer,” Clinical and Translational Oncology, vol. 8, no. 5, pp. 330–333, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Terashima and M. Kanaqawa, “Lung cancer with skin metastasis,” Chest, vol. 106, no. 5, pp. 1448–1450, 1994. View at Publisher · View at Google Scholar
  31. V. L. Keedy, S. Temin, M. R. Somerfield et al., “American Society of clinical oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy,” Journal of Clinical Oncology, vol. 29, no. 15, pp. 2121–2127, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. G. M. Stella, R. Scabini, S. Inghilleri et al., “EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells,” Journal of Cancer Research and Clinical Oncology, vol. 139, no. 8, pp. 1327–1335, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. E. L. Kwak, Y. J. Bang, D. R. Camidge et al., “Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer,” The New England Journal of Medicine, vol. 363, no. 18, pp. 1693–1703, 2010. View at Publisher · View at Google Scholar
  34. L. Crinò, D. Kim, G. J. Riely et al., “Initial phase II results with crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC): PROFILE 1005,” Journal of Clinical Oncology, vol. 29, supplement 15, 2011, ASCO Annual Meeting, Abstract 7514. View at Google Scholar
  35. A. T. Shaw, D.-W. Kim, R. Mehra et al., “Ceritinib in ALK-rearranged non-small-cell lung cancer,” The New England Journal of Medicine, vol. 370, no. 13, pp. 1189–1197, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. A. T. Shaw, S.-H. I. Ou, and Y.-J. Bang, “Crizotinib in ROS1-rearranged non-small-cell lung cancer,” The New England Journal of Medicine, vol. 371, no. 2030-2031, pp. 1963–1971, 2014. View at Publisher · View at Google Scholar